Vancouver-Based Nanomedicine Startup Targets Genetic Solution to Diseases

Press Release

February 25, 2016

February 25, 2016 – Vancouver, BC, Canada

The Vancouver Sun recently featured Precision NanoSystems in the health section to highlight the NanoAssemblr Platform as the next generation manufacturing platform for nanomedicines.

Randy Shore of the Vancouver Sun writes, “Using the unique physics of fluids at the nano-scale, the NanoAssemblr combines active ingredients — such as therapeutic strands of DNA or RNA — with complementary particles such as fatty molecules to form a kind of armoured transport. The active ingredients are encapsulated until they reach their target.”

Read the full article and view the interview with Precision NanoSystems’ CEO and co-founder, James Taylor.


IN THE NEWS

Press Release

Precision NanoSystems Inc. (PNI), a biotechnology company dedicated to helping advance innovative nanotechnology solutions for the molecular understanding and treatment of disease, welcomes industry veteran Ana-Paula Fernandes as Vice President of ...

Read More


Press Release

As a New Exporter finalist, PNI has demonstrated rapid growth in product exports globally. Although Canada and the US figure prominently in PNI’s portfolio, the technical sales team has also developed Australia, Asia, the Middle East and Euro...

Read More